Compare SPRY & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRY | STAA |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | 163 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 833.1M | 867.9M |
| IPO Year | 2020 | 1995 |
| Metric | SPRY | STAA |
|---|---|---|
| Price | $8.41 | $20.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 9 |
| Target Price | ★ $40.00 | $22.19 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $84,278,000.00 | ★ $239,442,000.00 |
| Revenue This Year | $90.76 | $27.04 |
| Revenue Next Year | $81.70 | $7.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.66 | $14.69 |
| 52 Week High | $18.63 | $30.81 |
| Indicator | SPRY | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 48.60 | 64.44 |
| Support Level | $8.33 | $16.60 |
| Resistance Level | $8.70 | $27.80 |
| Average True Range (ATR) | 0.56 | 1.02 |
| MACD | 0.08 | 0.29 |
| Stochastic Oscillator | 63.48 | 99.04 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.